Product Description
150mg Erlotinib Tablets IP is a potent anti-cancer medication that belongs to the class of tyrosine kinase inhibitors. It is used for the treatment of non-small cell lung cancer and pancreatic cancer. Each tablet contains 150mg of erlotinib as the active ingredient. These tablets are made with 100% yeast and have been manufactured in India. They come in a tablet form and have a shelf life of 6-12 months when stored in a cool place.
FAQs of 150mg Erlotinib Tablets IP:
Q: How does 150mg Erlotinib Tablets IP work?
A: 150mg Erlotinib Tablets IP is a tyrosine kinase inhibitor that blocks the activity of an enzyme called epidermal growth factor receptor (EGFR). EGFR is responsible for the growth and division of cancer cells. By inhibiting the activity of EGFR, 150mg Erlotinib Tablets IP slows down the growth and spread of cancer cells.
Q: How should I take 150mg Erlotinib Tablets IP?
A: You should take 150mg Erlotinib Tablets IP exactly as prescribed by your doctor. The usual recommended dose is one tablet per day. You should take the tablet on an empty stomach, at least one hour before or two hours after a meal. Swallow the tablet whole with water, do not crush, chew or break the tablet.
Q: What should I do if I miss a dose of 150mg Erlotinib Tablets IP?
A: If you miss a dose of 150mg Erlotinib Tablets IP, you should take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take the next dose at the scheduled time. Do not take a double dose to make up for the missed dose.
Q: What are the possible side effects of 150mg Erlotinib Tablets IP?
A: The common side effects of 150mg Erlotinib Tablets IP include rash, diarrhea, fatigue, nausea, vomiting, and loss of appetite. These side effects are usually mild to moderate in intensity and can be managed with supportive care. However, if you experience any severe or persistent side effects, you should contact your doctor immediately.
Q: Can I drive or operate machinery while taking 150mg Erlotinib Tablets IP?
A: 150mg Erlotinib Tablets IP may cause dizziness, fatigue, or visual disturbances. Therefore, it is recommended to avoid driving or operating machinery if you experience any of these side effects while taking the medication.